Selected article for: "day day and previous day"

Author: Linder, Kathleen A; McDonald, Philip J; Kauffman, Carol A; Revankar, Sanjay G; Chandrasekar, Pranatharthi H; Miceli, Marisa H
Title: Infectious Complications After Umbilical Cord Blood Transplantation for Hematological Malignancy
  • Document date: 2019_2_22
  • ID: qu20hqch_6
    Snippet: Infectious episodes were defined as episodes of fever or hemodynamic instability for which antimicrobial therapy was initiated and which were separated by at least 48 hours from previous episodes. Day of episode was counted as the first day of antimicrobial administration. The timing of neutrophil engraftment after UCBT was defined as the first of 3 consecutive days when the absolute neutrophil count was >500/μL. Graft-versushost disease, veno-o.....
    Document: Infectious episodes were defined as episodes of fever or hemodynamic instability for which antimicrobial therapy was initiated and which were separated by at least 48 hours from previous episodes. Day of episode was counted as the first day of antimicrobial administration. The timing of neutrophil engraftment after UCBT was defined as the first of 3 consecutive days when the absolute neutrophil count was >500/μL. Graft-versushost disease, veno-occlusive disease, and other complications related to the transplant, including infection, were defined in accordance with NCCN Guidelines [14] . Conditioning regimens were classified as either myeloablative or reduced-intensity using criteria proposed by Bacigalupo et al [15] . National Institute of Allergy and Infectious Diseases Mycoses Study Group criteria were used for the definition of invasive fungal infections [16] . Cytomegalovirus infection and end-organ disease were defined by current consensus definitions [17] . Routine screening for CMV viremia was not performed; molecular testing for CMV, HHV-6, and Epstein-Barr virus was performed with febrile episodes.

    Search related documents:
    Co phrase search for related documents
    • antimicrobial therapy and CMV viremia: 1
    • antimicrobial therapy and cytomegalovirus infection: 1
    • antimicrobial therapy and end organ: 1
    • antimicrobial therapy and febrile episode: 1
    • antimicrobial therapy and fungal infection: 1, 2, 3, 4, 5, 6
    • CMV viremia and conditioning regimen: 1
    • CMV viremia and end organ: 1
    • CMV viremia and end organ disease: 1
    • CMV viremia and Epstein Barr virus: 1, 2, 3
    • CMV viremia and fungal infection: 1, 2, 3, 4
    • conditioning regimen and fungal infection: 1
    • consensus definition and current consensus definition: 1, 2, 3, 4
    • cytomegalovirus infection and end organ: 1, 2, 3
    • cytomegalovirus infection and end organ disease: 1, 2, 3
    • cytomegalovirus infection and end organ disease cytomegalovirus infection: 1
    • cytomegalovirus infection and Epstein Barr virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • cytomegalovirus infection and fungal infection: 1, 2, 3, 4, 5
    • Epstein Barr virus and fungal infection: 1, 2, 3